{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:36:23Z","timestamp":1791336983298,"version":"4.3.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2021-12372433"],"award-info":[{"award-number":["RF-2021-12372433"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MultiMedica, Italy","award":["Ricerca corrente"],"award-info":[{"award-number":["Ricerca corrente"]}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["I43C24000120006"],"award-info":[{"award-number":["I43C24000120006"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG 2024 ID 30689"],"award-info":[{"award-number":["IG 2024 ID 30689"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Little is known as to whether there may be a patogenetic continuum among subsets of lung neuroendocrine neoplasms (NENs), including both neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs). In this study, transcriptomic data from 205 pulmonary NETs and NECs were collected from four publicly available datasets and analyzed through supervised clustering of a curated 20-gene signature dealing with neuroendocrine differentiation, key oncogenic pathways, chromatin remodeling genes, and lineage-specific transcription factors. Two major clusters were identified, PNEN-A and PNEN-B. Compared to PNEN-A and independently of histological typing, PNEN-B demonstrated reduced neuroendocrine gene expression and increased activation of pulmonary epithelial cell lineages, such as glandular (club\/AT2\u207a), basal (\u0394Np63\u207a\/p63\u207a\/CK5\u207a), and tuft cell (POU2F3\u207a) differentiation. PNEN-B tumors also exhibited features of inflamed but functionally constrained immune microenvironment, with increased expression of immunomodulatory neuropeptides (calcitonin, proopiomelanocortin, and gastrin-releasing peptide), alongside enrichment of T cell exhaustion markers. PNEN-B tumors significantly correlated with poor prognosis in a subset of cases. These findings reveal common transcriptional programs across the entire spectrum of pulmonary NENs, independent of histological typing. Attenuation of neuroendocrine differentiation, activation of alternative cell lineages, and modulation of microenvironment highlight subsets of tumors with potential pathogenetic and clinical implications.<\/jats:p>","DOI":"10.1186\/s13046-026-03790-8","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:27:28Z","timestamp":1785252448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptional evidence of neuroendocrine cell plasticity beyond histological boundaries in lung neuroendocrine neoplasms: an in-silico analysis suggesting a progression model"],"prefix":"10.1186","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4725-4692","authenticated-orcid":false,"given":"Giuseppe","family":"Pelosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2713-1700","authenticated-orcid":false,"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6322-4451","authenticated-orcid":false,"given":"Riccardo","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4018-3983","authenticated-orcid":false,"given":"Eleonora","family":"Duregon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1143-0252","authenticated-orcid":false,"given":"Maria","family":"Gemelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8629-7391","authenticated-orcid":false,"given":"Sergio","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-4316","authenticated-orcid":false,"given":"Angelica","family":"Sonzogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7458-3366","authenticated-orcid":false,"given":"Alice","family":"Laffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5684-5254","authenticated-orcid":false,"given":"Tommaso","family":"De Pas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2926-4663","authenticated-orcid":false,"given":"Chiara","family":"Catania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8002-1607","authenticated-orcid":false,"given":"Barbara","family":"Bassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4897-0420","authenticated-orcid":false,"given":"Fiorenza","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4790-0861","authenticated-orcid":false,"given":"Antonino","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0339-8520","authenticated-orcid":false,"given":"Paola","family":"Muti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-8638","authenticated-orcid":false,"given":"Fabrizio","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"3790_CR1","volume-title":"WHO classification of tumours: thoracic tumours","author":"C Borczuk","year":"2021","unstructured":"Borczuk C, Cooper W, Dacic S, Galateau-Salle F, Jain D, Kerr K, et al. WHO classification of tumours: thoracic tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2021.","edition":"5th ed"},{"key":"3790_CR2","doi-asserted-by":"publisher","unstructured":"Joshi A, Bhaskar N, Pearson JD. Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications. Cancers (Basel). 2025;17(2). https:\/\/doi.org\/10.3390\/cancers17020260.","DOI":"10.3390\/cancers17020260"},{"issue":"7654","key":"3790_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature22323","volume":"545","author":"JS Lim","year":"2017","unstructured":"Lim JS, Ibaseta A, Fischer MM, Cancilla B, O\u2019Young G, Cristea S, et al. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature. 2017;545(7654):360\u20134.","journal-title":"Nature."},{"issue":"1","key":"3790_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100308","volume":"7","author":"M Simbolo","year":"2022","unstructured":"Simbolo M, Centonze G, Ali G, Garzone G, Taormina S, Sabella G, et al. Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities. ESMO Open. 2022;7(1):100308.","journal-title":"ESMO Open"},{"issue":"1","key":"3790_CR5","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","volume":"9","author":"J George","year":"2018","unstructured":"George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, et al. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nat Commun. 2018;9(1):1048.","journal-title":"Nat Commun."},{"issue":"9","key":"3790_CR6","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/ijc.34193","volume":"151","author":"LH Yang","year":"2022","unstructured":"Yang LH, Lee RK, Kuo MH, Miao CC, Wang YX, Chen A, et al. Neuronal survival factor VGF promotes chemoresistance and predicts poor prognosis in lung cancers with neuroendocrine feature. Int J Cancer. 2022;151(9):1611\u201325.","journal-title":"Int J Cancer"},{"issue":"2","key":"3790_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cell.2019.09.010","volume":"179","author":"Y Ouadah","year":"2019","unstructured":"Ouadah Y, Rojas ER, Riordan DP, Capostagno S, Kuo CS, Krasnow MA. Rare pulmonary neuroendocrine cells are stem cells regulated by Rb, p53, and Notch. Cell. 2019;179(2):403-16 e23.","journal-title":"Cell"},{"key":"3790_CR8","doi-asserted-by":"publisher","unstructured":"Kuo CS, Darmanis S, Diaz de Arce A, Liu Y, Almanzar N, Wu TT, et al. Neuroendocrinology of the lung revealed by single-cell RNA sequencing. Elife. 2022;11. https:\/\/doi.org\/10.7554\/eLife.78216.","DOI":"10.7554\/eLife.78216"},{"key":"3790_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.663535","volume":"9","author":"GF Pavon-Romero","year":"2021","unstructured":"Pavon-Romero GF, Serrano-Perez NH, Garcia-Sanchez L, Ramirez-Jimenez F, Teran LM. Neuroimmune pathophysiology in asthma. Front Cell Dev Biol. 2021;9:663535.","journal-title":"Front Cell Dev Biol"},{"issue":"6410","key":"3790_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aat5749","volume":"362","author":"JW Park","year":"2018","unstructured":"Park JW, Lee JK, Sheu KM, Wang L, Balanis NG, Nguyen K, et al. Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science. 2018;362(6410):91\u20135.","journal-title":"Science"},{"issue":"3","key":"3790_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"6","key":"3790_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189007","volume":"1878","author":"J Li","year":"2023","unstructured":"Li J, Che M, Zhang B, Zhao K, Wan C, Yang K. The association between the neuroendocrine system and the tumor immune microenvironment: emerging directions for cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(6):189007.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"9","key":"3790_CR13","doi-asserted-by":"publisher","first-page":"R329","DOI":"10.1530\/ERC-20-0113","volume":"27","author":"TJ Takkenkamp","year":"2020","unstructured":"Takkenkamp TJ, Jalving M, Hoogwater FJH, Walenkamp AME. The immune tumour microenvironment of neuroendocrine tumours and its implications for immune checkpoint inhibitors. Endocr Relat Cancer. 2020;27(9):R329\u201343.","journal-title":"Endocr Relat Cancer"},{"issue":"7563","key":"3790_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524(7563):47\u201353.","journal-title":"Nature."},{"issue":"7","key":"3790_CR15","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/1078-0432.CCR-17-0252","volume":"24","author":"MK Asiedu","year":"2018","unstructured":"Asiedu MK, Thomas CF Jr., Dong J, Schulte SC, Khadka P, Sun Z, et al. Pathways impacted by genomic alterations in pulmonary carcinoid tumors. Clin Cancer Res. 2018;24(7):1691\u2013704.","journal-title":"Clin Cancer Res"},{"issue":"17","key":"3790_CR16","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-19-0214","volume":"79","author":"SV Laddha","year":"2019","unstructured":"Laddha SV, da Silva EM, Robzyk K, Untch BR, Ke H, Rekhtman N, et al. Integrative genomic characterization identifies molecular subtypes of lung carcinoids. Cancer Res. 2019;79(17):4339\u201347.","journal-title":"Cancer Res"},{"issue":"9","key":"3790_CR17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jtho.2022.06.004","volume":"17","author":"MK Baine","year":"2022","unstructured":"Baine MK, Febres-Aldana CA, Chang JC, Jungbluth AA, Sethi S, Antonescu CR, et al. POU2F3 in SCLC: clinicopathologic and genomic analysis with a focus on its diagnostic utility in neuroendocrine-low SCLC. J Thorac Oncol. 2022;17(9):1109\u201321.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3790_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/PAS.0000000000002145","volume":"48","author":"N Jimbo","year":"2024","unstructured":"Jimbo N, Ohbayashi C, Takeda M, Fujii T, Mitsui S, Tsukamoto R, et al. POU2F3-expressing small cell lung carcinoma and large cell neuroendocrine carcinoma show morphologic and phenotypic overlap. Am J Surg Pathol. 2024;48(1):4\u201315.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"3790_CR19","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jtho.2021.07.018","volume":"16","author":"BH Herzog","year":"2021","unstructured":"Herzog BH, Devarakonda S, Govindan R. Overcoming chemotherapy resistance in SCLC. J Thorac Oncol. 2021;16(12):2002\u201315.","journal-title":"J Thorac Oncol"},{"key":"3790_CR20","doi-asserted-by":"publisher","unstructured":"Stewart CA, Diao L, Xi Y, Wang R, Ramkumar K, Serrano AG, et al. YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities. Clin Cancer Res. 2024. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-0361.","DOI":"10.1158\/1078-0432.CCR-24-0361"},{"key":"3790_CR21","doi-asserted-by":"publisher","unstructured":"Pelosi G, Gemelli M, Bianchi F, Papotti M, Duregon E, Ricotta R, et al. Modeling large cell neuroendocrine carcinoma of the lung for molecular, therapeutic and microenvironmental inferences: current knowledge and future perspectives. Expert Rev Anticancer Ther. 2025:1-24. https:\/\/doi.org\/10.1080\/14737140.2025.2523544.","DOI":"10.1080\/14737140.2025.2523544"},{"key":"3790_CR22","doi-asserted-by":"publisher","unstructured":"Pelosi G, Laffi A, Catalano G, Bruno A, Papotti M, Bassani B, et al. Pathology, molecular biology, medical oncology, and radiotherapy implications of lung neuroendocrine neoplasm classification: a multidisciplinary perspective. Expert Rev Anticancer Ther. 2025:1-37. https:\/\/doi.org\/10.1080\/14737140.2025.2584486.","DOI":"10.1080\/14737140.2025.2584486"},{"issue":"8","key":"3790_CR23","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.ccell.2024.06.012","volume":"42","author":"L Duplaquet","year":"2024","unstructured":"Duplaquet L, So K, Ying AW, Pal Choudhuri S, Li X, Xu GD, et al. Mammalian SWI\/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer. Cancer Cell. 2024;42(8):1352-69 e13.","journal-title":"Cancer Cell"},{"issue":"8088","key":"3790_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-025-09503-z","volume":"647","author":"AS Ireland","year":"2025","unstructured":"Ireland AS, Xie DA, Hawgood SB, Barbier MW, Zuo LY, Hanna BE, et al. Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer. Nature. 2025;647(8088):257\u201367.","journal-title":"Nature"},{"issue":"2","key":"3790_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1046\/j.1365-2559.2003.01541.x","volume":"42","author":"N Sturm","year":"2003","unstructured":"Sturm N, Rossi G, Lantuejoul S, Laverriere MH, Papotti M, Brichon PY, et al. 34BetaE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma. Histopathology. 2003;42(2):156\u201366.","journal-title":"Histopathology."},{"issue":"3","key":"3790_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1066896913476750","volume":"21","author":"G Pelosi","year":"2013","unstructured":"Pelosi G, Rossi G, Cavazza A, Righi L, Maisonneuve P, Barbareschi M, et al. DeltaNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization. Int J Surg Pathol. 2013;21(3):229\u201339.","journal-title":"Int J Surg Pathol."},{"issue":"6","key":"3790_CR27","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1172\/JCI130426","volume":"130","author":"G Alvisi","year":"2020","unstructured":"Alvisi G, Brummelman J, Puccio S, Mazza EM, Tomada EP, Losurdo A, et al. IRF4 instructs effector Treg differentiation and immune suppression in human cancer. J Clin Invest. 2020;130(6):3137\u201350.","journal-title":"J Clin Invest"},{"issue":"2","key":"3790_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccell.2023.12.013","volume":"42","author":"D Memon","year":"2024","unstructured":"Memon D, Schoenfeld AJ, Ye D, Fromm G, Rizvi H, Zhang X, et al. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer. Cancer Cell. 2024;42(2):209-24 e9.","journal-title":"Cancer Cell"},{"issue":"9","key":"3790_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jtho.2022.07.001","volume":"17","author":"R Matsuoka","year":"2022","unstructured":"Matsuoka R, Kawai H, Ito T, Matsubara D. Determining whether YAP1 and POU2F3 are antineuroendocrine factors. J Thorac Oncol. 2022;17(9):1070\u20133.","journal-title":"J Thorac Oncol"},{"key":"3790_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2024.104882","volume":"135","author":"G Pelosi","year":"2024","unstructured":"Pelosi G, Melocchi V, Dama E, Hofman P, De Luca M, Albini A, et al. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms. Exp Mol Pathol. 2024;135:104882.","journal-title":"Exp Mol Pathol"},{"issue":"43","key":"3790_CR31","doi-asserted-by":"publisher","first-page":"73745","DOI":"10.18632\/oncotarget.20572","volume":"8","author":"K McColl","year":"2017","unstructured":"McColl K, Wildey G, Sakre N, Lipka MB, Behtaj M, Kresak A, et al. Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer. Oncotarget. 2017;8(43):73745\u201356.","journal-title":"Oncotarget"},{"key":"3790_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadva.2022.100052","volume":"2","author":"CH Li","year":"2022","unstructured":"Li CH, Chan MH, Liang SM, Chang YC, Hsiao M. Fascin-1: Updated biological functions and therapeutic implications in cancer biology. BBA Adv. 2022;2:100052.","journal-title":"BBA Adv."},{"issue":"4","key":"3790_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/JTO.0000000000000459","volume":"10","author":"AF Gazdar","year":"2015","unstructured":"Gazdar AF, Savage TK, Johnson JE, Berns A, Sage J, Linnoila RI, et al. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J Thorac Oncol. 2015;10(4):553\u201364.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3790_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21037\/tlcr.2018.02.02","volume":"7","author":"W Zhang","year":"2018","unstructured":"Zhang W, Girard L, Zhang YA, Haruki T, Papari-Zareei M, Stastny V, et al. Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes. Transl Lung Cancer Res. 2018;7(1):32\u201349.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"3790_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-024-01572-3","volume":"17","author":"E Redin","year":"2024","unstructured":"Redin E, Sridhar H, Zhan YA, Pereira Mello B, Zhong H, Durani V, et al. SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing. J Hematol Oncol. 2024;17(1):58.","journal-title":"J Hematol Oncol."},{"key":"3790_CR36","doi-asserted-by":"publisher","unstructured":"von Itzstein MS, Drapkin BJ, Minna JD. How lung cancer cells change identity. Elife. 2021;10. https:\/\/doi.org\/10.7554\/eLIfe.71610.","DOI":"10.7554\/eLIfe.71610"},{"issue":"1","key":"3790_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccell.2019.06.005","volume":"36","author":"NG Balanis","year":"2019","unstructured":"Balanis NG, Sheu KM, Esedebe FN, Patel SJ, Smith BA, Park JW, et al. Pan-cancer convergence to a small-cell neuroendocrine phenotype that shares susceptibilities with hematological malignancies. Cancer Cell. 2019;36(1):17-34 e7.","journal-title":"Cancer Cell"},{"issue":"1","key":"3790_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/2159-8290.CD-24-0286","volume":"15","author":"N Rekhtman","year":"2025","unstructured":"Rekhtman N, Tischfield SE, Febres-Aldana CA, Lee JJ, Chang JC, Herzberg BO, et al. Chromothripsis-mediated small cell lung carcinoma. Cancer Discov. 2025;15(1):83\u2013104.","journal-title":"Cancer Discov"},{"issue":"4","key":"3790_CR39","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00428-018-2307-3","volume":"472","author":"G Pelosi","year":"2018","unstructured":"Pelosi G, Bianchi F, Dama E, Simbolo M, Mafficini A, Sonzogni A, et al. Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm. Virchows Arch. 2018;472(4):567\u201377.","journal-title":"Virchows Arch"},{"issue":"1","key":"3790_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","volume":"38","author":"AS Ireland","year":"2020","unstructured":"Ireland AS, Micinski AM, Kastner DW, Guo B, Wait SJ, Spainhower KB, et al. MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate. Cancer Cell. 2020;38(1):60-78 e12.","journal-title":"Cancer Cell"},{"issue":"40","key":"3790_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg1850","volume":"7","author":"Q Wu","year":"2021","unstructured":"Wu Q, Guo J, Liu Y, Zheng Q, Li X, Wu C, et al. YAP drives fate conversion and chemoresistance of small cell lung cancer. Sci Adv. 2021;7(40):eabg1850.","journal-title":"Sci Adv"},{"issue":"21","key":"3790_CR42","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1158\/1078-0432.CCR-22-1115","volume":"28","author":"CA Febres-Aldana","year":"2022","unstructured":"Febres-Aldana CA, Chang JC, Ptashkin R, Wang Y, Gedvilaite E, Baine MK, et al. Rb tumor suppressor in small cell lung cancer: combined genomic and IHC analysis with a description of a distinct Rb-proficient subset. Clin Cancer Res. 2022;28(21):4702\u201313.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3790_CR43","doi-asserted-by":"publisher","DOI":"10.2217\/lmt-2019-0005","volume":"8","author":"D Sonkin","year":"2019","unstructured":"Sonkin D, Thomas A, Teicher BA. Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity. Lung Cancer Manag. 2019;8(2):LMT13.","journal-title":"Lung Cancer Manag"},{"issue":"1","key":"3790_CR44","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1038\/s41467-019-11276-9","volume":"10","author":"N Alcala","year":"2019","unstructured":"Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T, et al. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Nat Commun. 2019;10(1):3407.","journal-title":"Nat Commun."},{"issue":"8005","key":"3790_CR45","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41586-024-07177-7","volume":"627","author":"J George","year":"2024","unstructured":"George J, Maas L, Abedpour N, Cartolano M, Kaiser L, Fischer RN, et al. Evolutionary trajectories of small cell lung cancer under therapy. Nature. 2024;627(8005):880\u20139.","journal-title":"Nature."}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03790-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03790-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03790-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:10:56Z","timestamp":1785521456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03790-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3790"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03790-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"8 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"168"}}